Sign-up
Sign-up
Sign-up
Research Project

Patient-Reported Outcomes/Metrics Program Trial - Palliative Radiation

What is the PROMPT Study?

The PROMPT Study is a 1-year clinical trial that will monitor the Quality of Life (QoL) of 100 patients that are undergoing radiotherapy. Principal Investigators, Dr. Aisling Barry and Dr. Philip Wong from Princess Margaret Cancer Centre, are using Zamplo to monitor QoL and toxicity monitoring in a clinical trial known as PROMPT - Palliative Radiation.

Hexoskin is a wearable smart shirt that has been used to monitor astronauts' physiology around the clock as they orbit the planet. In the PROMPT study, cancer patients scheduled for radiation therapy will be wearing the Hexoskin shirt to record their health data and will use Zamplo to monitor their symptoms. Patients will be able to see a daily summary of their Hexoskin data in Zamplo.

Screen Shot 2021-06-28 at 9.09.24 AM

How is Zamplo being used?

In the PROMPT study, cancer patients scheduled for radiation therapy will be using Zamplo to monitor their symptoms and see a daily summary of their health data.

Those involved in PROMPT will use Zamplo to:

Journals

Create Journal entries about medication, symptoms and health data
Journals

Routines

Create Routines to remind them of daily movement and exercises
Routines

Share

Share their virtual binder with their caregivers
Share

Track

Track medications and symptoms with the Zamplo app 
Track

Meet the Team

Dr. Philip Wong
Research Studies Headshots
Principal Investigator

Dr. Philip Wong

Dr. Philip Wong is a Radiation Oncologist at the Princess Margaret Cancer Centre. His interests include novel technologies in the care of cancer patients and the evaluation of patient-facing applications and biometric tools for the monitoring of patients undergoing treatments.

Research Studies Headshots (1)
Co-Principal Investigator

Dr. Aisling Barry

Dr. Aisling Barry is a Radiation Oncologist and consultant at  Princess Margaret Cancer Center in Toronto. Her research interests include primary and secondary liver cancer, and palliative radiotherapy, among others.

Your Health Data In Your Hands

New call-to-actionNew call-to-actionNew call-to-action